Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide and Metformin in Overweight/Obese PCOS with IGR
NCT03352869Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- Nov 2017
- Primary completion
- Jul 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in polycystic ovary syndrome (PCOS), sponsored by Renji Hospital. Started Nov 2017; status: completed.
02
Drugs
exenatide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03352869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03352869.